Novel imantib resistance mechanisms in chronic myloid leukemia
In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...
Kaydedildi:
Yazar: | |
---|---|
Diğer Yazarlar: | |
Materyal Türü: | Dissertation |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
Philipps-Universität Marburg
2007
|
Konular: | |
Online Erişim: | PDF Tam Metin |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
No citations were found for this record.